No Data
No Data
Ionis Pharmaceuticals Approaching Value Inflection: A Strong Buy on ION582's Efficacy and Competitive Edge
Analysts Conflicted on These Healthcare Names: Ionis Pharmaceuticals (IONS), Conmed (CNMD) and PTC Therapeutics (PTCT)
Analysts' Opinions Are Mixed on These Healthcare Stocks: Adaptimmune Therapeutics (ADAP), Ionis Pharmaceuticals (IONS) and Ultragenyx Pharmaceutical (RARE)
Ionis (IONS), Biogen Down on Ending Development of ALS Drug
Ionis Pharmaceuticals Buy Rating Affirmed on Strong Clinical Data and Robust Pipeline Potential
Analysts Are Bullish on These Healthcare Stocks: BioMarin Pharmaceutical (BMRN), Ionis Pharmaceuticals (IONS)
No Data